Zobrazeno 1 - 10
of 93
pro vyhledávání: '"ELEONORA LAI"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/75cde0ee853942c5838330933c358064
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/da9b18036b5548238d791feffb4f3a67
Autor:
Pina Ziranu, Andrea Pretta, Marta Pozzari, Antonio Maccioni, Manuela Badiali, Daniela Fanni, Eleonora Lai, Clelia Donisi, Mara Persano, Clara Gerosa, Marco Puzzoni, Fabio Bardanzellu, Rossano Ambu, Valeria Pusceddu, Marco Dubois, Giulia Cerrone, Marco Migliari, Sara Murgia, Dario Spanu, Gianluca Pretta, Valentina Aimola, Francesca Balconi, Stefania Murru, Gavino Faa, Mario Scartozzi
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Immune checkpoint inhibitors (ICIs) showed efficacy in metastatic colorectal cancer (mCRC) with mismatch-repair deficiency or high microsatellite instability (dMMR-MSI-H). Unfortunately, a patient’s subgroup did not benefit from immunother
Externí odkaz:
https://doaj.org/article/7e304fcff81540f09452e77c7fdf93fe
Autor:
Margherita Rimini, Carles Fabregat-Franco, Valentina Burgio, Sara Lonardi, Monica Niger, Mario Scartozzi, Ilario Giovanni Rapposelli, Giuseppe Aprile, Francesca Ratti, Federica Pedica, Helena Verdaguer, Mario Rizzato, Federico Nichetti, Eleonora Lai, Alessandro Cappetta, Teresa Macarulla, Matteo Fassan, Filippo De Braud, Andrea Pretta, Francesca Simionato, Francesco De Cobelli, Luca Aldrighetti, Lorenzo Fornaro, Stefano Cascinu, Andrea Casadei-Gardini
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract IDH1-mutated cholangiocarcinomas (CCAs) are an interesting group of neoplasia with particular behavior and therapeutic implications. The aim of the present work is to highlight the differences characterizing IDH1m and IDH1wt CCAs in terms of
Externí odkaz:
https://doaj.org/article/49008ad5b7a4484585f1c9926745098f
Autor:
Michele Dionese, Umberto Basso, Francesco Pierantoni, Eleonora Lai, Nicolò Cavasin, Elisa Erbetta, Salim Jubran, Giorgio Bonomi, Davide Bimbatti, Marco Maruzzo
Publikováno v:
Future Science OA, Vol 9, Iss 7 (2023)
Aim: Inflammation indexes had been associated with overall survival (OS) and immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICIs). Materials & methods: in 72 patients treated with ICIs for metastatic urot
Externí odkaz:
https://doaj.org/article/e7a92d8288ff47c9829ad4d408f11ea4
Autor:
Maria Ornella Nicoletto, Alessandra Baldoni, Francesco Cavallin, Andrea Grego, Cristina Falci, Margherita Nardin, Enzo Mammano, Eleonora Lai, Valter Torri
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: The use of PARP inhibitor (PARPi) has shown a considerable benefit in progression-free survival (PFS) in relapsed, platinum-sensitive epithelial ovarian cancer (OC). Objective: Our study aimed to investigate the impact of the last platinu
Externí odkaz:
https://doaj.org/article/9ed58ccb93c04822ab98dc828d26e551
Autor:
Davide Bimbatti, Michele Dionese, Eleonora Lai, Nicolò Cavasin, Umberto Basso, Alvise Mattana, Francesco Pierantoni, Vittorina Zagonel, Marco Maruzzo
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionImmunotherapy with nivolumab (a monoclonal antibody that targets the programmed cell death protein 1, PD1) has become the standard treatment for patients with metastatic renal cell carcinoma (mRCC) after progression to single-agent tyrosi
Externí odkaz:
https://doaj.org/article/e7c9bff5d3e444d686cbd29b7d26c867
Autor:
Stefano Mariani, Marco Puzzoni, Riccardo Giampieri, Pina Ziranu, Valeria Pusceddu, Clelia Donisi, Mara Persano, Giovanna Pinna, Erika Cimbro, Alissa Parrino, Dario Spanu, Andrea Pretta, Eleonora Lai, Nicole Liscia, Alessio Lupi, Enrica Giglio, Grazia Palomba, Milena Casula, Marina Pisano, Giuseppe Palmieri, Mario Scartozzi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundRechallenge with EGFR inhibitors represents a promising strategy for patients with RAS wild type (WT) colorectal cancer (CRC) but definitive selection criteria are lacking. Recently, the RAS WT status on circulating tumor DNA (ct-DNA) emerg
Externí odkaz:
https://doaj.org/article/7c74f9145f1d405983f83568cd2f0eab
Autor:
Federica Sancassiani, Elena Massa, Carla Pibia, Giulia Perda, Laura Boe, Elena Fantozzi, Giulia Cossu, Giovanni Caocci, Olga Mulas, Emanuela Morelli, Jutta Lindert, Eleonora Lai, Antonio Egidio Nardi, Mario Scartozzi, Giorgio La Nasa, Mauro Giovanni Carta
Publikováno v:
Journal of Public Health Research (2021)
Background: the aim was to verify the association between Major Depressive Disorders (MDD) and the risk of premature death in people with oncological diseases, and to collect evidence about the causality of a possible association from a longitudinal
Externí odkaz:
https://doaj.org/article/59509a3199e74392a7d0049e1e4912ca
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Targeting tumor-driven angiogenesis is an effective strategy in the management of metastatic colorectal cancer (mCRC); however, the choice of second-line therapy is complicated by the availability of several drugs, the occurrence of resistance and th
Externí odkaz:
https://doaj.org/article/648f51dfd4ed4508afe5342122bdfdeb